Abstract
Sendai virus (SeV), a prototypic member of the family Paramyxoviridae, was discovered in 1953, six decades ago. It is not just an old mouse pathogen but has been an irreplaceable model in in basic research to understand paramyxovirus replication and pathogenesis. The SeV reverse genetics established in 1996 has played a particularly prominent role in this context by settling outstanding issues and resolving enigmas. At the same time, the technology is evolving into a multipurpose cytoplasmic (nonintegrating) RNA vector. Its diverse medical applications are now in the pipeline and being tested in clinical settings as illustrated in the subsequent chapters. The production of diverse target-oriented devices has been possible by making full use of a variety of SeV theories and traits discovered during the six decades. Here, we summarize the long journey of SeV research leading up to the invention of this novel class of expression vector, SeV vector.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ali A, Nayak DP (2000) Assembly of Sendai virus: M protein interacts with F and HN proteins and with the cytoplasmic tail and transmembrane domain of F protein. Virology 276:289–303
Babst M, Wendland B, Estepa EJ, Emr SD (1998) The Vps4p AAA ATPase regulates membrane association of a Vps protein complex required for normal endosome function. EMBO J 17:2982–2993
Bächi T (1980) Intramembrane structural differentiation in Sendai virus maturation. Virology 106:41–49
Bieniasz PD (2006) Late budding domains and host proteins in enveloped virus release. Virology 344:55–63
Billeter MA, Cattaneo R (1991) Molecular biology of defective measles viruses persisting in the human central nervous system. In: Kingsbury DW (ed) The paramyxoviruses. Plenum Press, New York
Bitzer M, Lauer U, Baumann C, Spiegel M, Gregor M, Neubert WJ (1997) Sendai virus efficiently infects cells via the asialoglycoprotein receptor and requires the presence of cleaved F0 precursor proteins for this alternative route of cell entry. J Virol 71:5481–5486
Blanchard L, Tarbouriech N, Blackledge M, Timmins P, Burmeister WP, Ruigrok RWH, Marion D (2004) Structure and dynamics of the nucleocapsid-binding domain of the Sendai virus phosphoprotein in solution. Virology 319:201–211
Bossow S, Schiecht S, Schubbert R, Pfeiffer M, Neubert WJ, Wiegand M (2012) Evaluation of nucleocapsid and phosphoprotein P functionality as critical factors during the early phase of paramyxoviral infection. Open Virol J 6:73–81. doi:10.2174/1874357901206010073
Böttcher E, Freuer C, Steinmetzer T, Klenk HD, Garten W (2006) MDCK cells that express proteases TMPRSS2 and HAT provide a cell system to propagate influenza viruses in the absence of trypsin and to study cleavage of HA and its inhibition. Vaccine 27:6324–6329
Bousse T, Takimoto T (2006) Mutation at residue 523 creates a second receptor binding site on human parainfluenza virus type 1 hemagglutinin-neuraminidase protein. J Virol 80:9009–9016
Buchholz CJ, Spehner D, Drillien R, Neubert WJ, Homann HE (1993) The conserved N-terminal region of Sendai virus nucleocapsid protein NP is required for nucleocapsid assembly. J Virol 67:5803–5812
Cadd T, Garcin D, Tapparel C, Itoh M, Homma M, Roux L, Curran J, Kolakofsky D (1996) The Sendai paramyxovirus accessory C proteins inhibit viral genome amplification in a promoter-specific fashion. J Virol 70:5067–5074
Calain P, Roux L (1993) The rule of six, a basic feature for efficient replication of Sendai virus defective interfering RNA. J Virol 67:4822–4830
Calistri A, Salata C, Parolin C, Palù G (2009) Role of multivesicular bodies and their components in the egress of enveloped RNA viruses. Rev Med Virol 19:21–45
Çevik B, Kaesberg J, Smallwood S, Feller JA, Moyer SA (2004) Mapping the phosphoprotein binding site on Sendai virus NP protein assembled into nucleocapsids. Virology 325:216–224
Çevik B, Smallwood S, Moyer SA (2007) Two N-terminal regions of the Sendai virus L RNA polymerase protein participate in oligomerization. Virology 363:189–197
Chaipan C, Kabasa D, Bertram S, Glowacka I, Steffen I, Tsegaye TS, Takeda M, Bugge TH, Kim S, Park Y, Marzi A, Pöhlmann S (2009) Proteolytic activation of the 1918 influenza virus hemagglutinin. J Virol 83:3200–3211
Chambers R, Takimoto T (2010) Trafficking of Sendai virus nucleocapsids is mediated by intracellular vesicles. PLoS One 5:e10994. doi:10.137/journal.pone.0010994
Chandrika R, Horikami SM, Smallwood S, Moyer SA (1995) Mutations in conserved domain I of the Sendai virus L polymerase protein uncouple transcription and replication. Virology 213:352–363
Chattopadhyay S, Marques JT, Yamashita M, Peters KL, Smith K, Desai A, Williams BR, Sen GC (2010) Viral apoptosis is induced by IRF-3-mediated activation of bax. EMBO J 29:1762–1773
Choppin PW, Compans RW (1975) Reproduction of paramyxoviruses. In: Fraenkel-Conrat H, Wagner RR (eds) Comprehensive virology, vol 4. Plenum Press, New York
Cortese CK, Feller JA, Moyer SA (2000) Mutations in domain V and the Sendai virus L polymerase protein uncouple transcription and replication and differentially affect replication in vitro and in vivo. Virology 277:387–396
Curran J (1996) Reexamination of the Sendai virus P protein domains required for RNA synthesis: a possible supplemental role for the P protein. Virology 221:130–140
Curran J (1998) A role for the Sendai virus P protein trimer in RNA synthesis. J Virol 72:4274–4280
Curran J, Kolakofsky D (1987) Identification of an additional Sendai virus non-structural protein encoded by the P/C mRNA. J Gen Virol 68:2515–2519
Curran J, Kolakofsky D (1988a) Ribosomal initiation from an ACG codon in the Sendai virus P/C mRNA. EMBO J 7:245–251
Curran J, Kolakofsky D (1988b) Scanning independent ribosomal initiation of the Sendai virus X protein. EMBO J 7:2869–2874
Curran J, Kolakofsky D (1989) Scanning independent ribosomal initiation of the Sendai virus Y proteins in vitro and in vivo. EMBO J 8:521–526
Curran J, Kolakofsky D (2008) Nonsegmented negative-strand RNA virus RNA synthesis in vivo. Virology 371:227–230
Curran J, Boeck R, Kolakofsky D (1991) The Sendai virus P gene expresses both an essential protein and an inhibitor of RNA synthesis by shuffling modules via mRNA editing. EMBO J 10:3079–3085
Curran J, Marq J-B, Kolakofsky D (1992) The Sendai virus nonstructural C proteins specifically inhibit viral mRNA synthesis. Virology 189:647–656
Curran J, Homann H, Buchholz C, Rochat S, Neubert W, Kolakofsky D (1993) The hypervariable C-terminal tail of the Sendai paramyxovirus nucleocapsid protein in required for template function but not for RNA encapsidation. J Virol 67:4358–4364
Curran J, Pelet T, Kolakofsky D (1994) An acidic activation-like domain of the Sendai virus P protein is required for RNA synthesis and encapsidation. Virology 202:875–884
Curran J, Marq J-B, Kolakofsky D (1995) An N-terminal domain of the Sendai paramyxovirus P protein acts as a chaperone for the NP protein during the nascent chain assembly step of genome replication. J Virol 69:849–855
de Breyne S, Monney RS, Curran J (2004) Proteolytic processing and translation initiation: two independent mechanisms for the expression of the Sendai virus Y proteins. J Biol Chem 279:16571–16580
Delenda C, Hausmann S, Garcin D, Kolakofsky D (1997) Normal cellular replication of Sendai virus without the trans-frame, nonstructural V protein. Virology 228:55–62
Demirov DG, Freed EO (2004) Retrovirus budding. Virus Res 106:87–102
Didcock L, Young DF, Goodbourn S, Randall RE (1999a) Sendai virus and simian virus 5 block activation of interferon-responsive genes: importance for virus pathogenesis. J Virol 73:3125–3133
Didcock L, Young DF, Goodbourn S, Randall RE (1999b) The V protein of simian virus 5 inhibits interferon signalling by targeting STAT1 for proteasome-mediated degradation. J Virol 73:9928–9933
Drexler JF, Corman VM, Müller MA, Maganda GD, Vallo P, Binger T, Gloza-Rausch F, Rasche A, Yordanov S, Seebens A, Oppong S, Sarkodie Y, Pngombo C, Lukashev AN, Schmidt-Chanasit J, Stöcker A, Carneiro AJ, Erbar S, Maisner A, Fronhoffs F, Buettner R, Kalko EK, Kruppa T, Franke CR, Kallies R, Yandoko ER, Herrler G, Reusken C, Hassanin A, Krüger DH, Matthee S, Ulrich RF, Leroy EM, Drosten C (2012) Bats host major mammalian paramyxoviruses. Nat Commun 3:796. doi:10.1038/ncomms1796
Easterbrook JD, Kaplan JB, Glass GE, Watson J, Klein SL (2008) A survey of rodent-borne pathogens carried by wild-caught Norway rats: a potential threat to laboratory rodent colonies. Lab Anim 42:92–98
Egelman EH, Wu S-S, Amrein M, Portner A, Murti G (1989) The Sendai virus nucleocapsid exists in at least four different helical states. J Virol 63:2233–2243
Einberger H, Mertz R, Hofschneider PH, Neubert WJ (1990) Purification, renaturation, and reconstituted protein kinase activity of the Sendai virus large (L) protein: L protein phosphorylates the NP and P proteins in vitro. J Virol 64:4274–4280
Feller JA, Smallwood S, Horikami SM, Moyer SA (2000) Mutations in conserved domains IV and VI of the large (L) subunit of the Sendai virus RNA polymerase give an spectrum of defective RNA synthesis phenotypes. Virology 269:426–439
Finch JT, Gibbs AJ (1970) Observations on the suructure of the nucleocapsids of some paramyxoviruses. J Gen Virol 6:141–150
Fuerst TR, Niles EG, Studier FW, Moss B (1986) Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase. Proc Natl Acad Sci USA 83:8122–8126
Fujii Y, Kiyotani K, Yashida T, Sakaguchi T (2001) Conserved and non-conserved regions in the Sendai virus genome: evolution of a gene possessing overlapping reading frames. Virus Genes 22:47–52
Fukuhara N, Huang C, Kiyotani K, Yoshida T, Sakaguchi T (2002) Mutational analysis of the Sendai virus V protein: importance of the conserved residues for Zn binding, virus pathogenesis and efficient RNA editing. Virology 299:172–178
Fukumi H, Nishikawa F, Kitayama T (1954) A pneumotropic virus from mice causing hemagglutination. Jpn J Med Sci Biol 7:345–363
Galinski MS, Troy RM, Banerjee AK (1992) RNA editing in the phosphoprotein gene of the human parainfluenza virus type 3. Virology 186:543–550
Garcin D, Pelet T, Calain P, Roux L, Curran J, Kolakofsky D (1995) A highly recombinogenic system for the recovery of infections Sendai paramyxovirus from cDNA: generation of a novel copy-back nondefective interfering virus. EMBO J 14:6087–6094
Garcin D, Latorre P, Kolakofsky D (1999) Sendai virus C proteins counteract the interferon-mediated induction of an antiviral state. J Virol 73:6559–6565
Gething MJ, White JM, Waterfield MD (1978) Purification of the fusion protein of Sendai virus: analysis of the NH2-terminal sequence generated during precursor activation. Proc Natl Acad Sci USA 75:2737–2740
Goff PH, Gao Q, Palese P (2012) A majority of infectious Newcastle disease virus particles packages a single genome while a minority is multiploid. J Virol 86:10852–10856
Gosselin-Grenet AS, Mottet-Osman G, Roux L (2006) From assembly to virus particle budding: pertinence of the detergent resistant membranes. Virology 344:296–303
Gosselin-Grenet AS, Marq JB, Abrami L, Garcin D, Roux L (2007) Sendai virus budding in the course of an infection does not require Alix and VPS4A host factors. Virology 365:101–112
Gotoh B, Ogasawara T, Toyoda T, Inocencio NM, Hamaguchi M, Nagai Y (1990) An endoprotease homologous to the blood clotting factor X as a determinant of viral tropism in chick embryo. EMBO J 9:4189–4195
Gotoh B, Takeuchi K, Komatsu T, Yokoo J, Kimura Y, Kato A, Kurotani A, Nagai Y (1999) Knockout of the Sendai virus C genes eliminates the viral ability to prevent the interferon-α/β mediated responses. FEBS Lett 459:205–210
Gotoh B, Komatsu T, Takeuchi K, Yokoo J (2001) Paramyxovirus accessory proteins as interferon antagonists. Microbiol Immunol 45:787–800
Gotoh B, Komatsu T, Takeuchi K, Yokoo J (2002) Paramyxovirus strategies for evading the interferon response. Rev Med Virol 12:337–357
Gotoh B, Komatsu T, Takeuchi K, Yokoo J (2003a) The C-terminal half-fragment of the Sendai virus C protein prevents the gamma-activated factor from binding to a gamma-activated sequence site. Virology 316:29–40
Gotoh B, Takeuchi K, Komatsu T, Yokoo J (2003b) The STAT2 activation process is a crucial target of Sendai virus C protein for the blockade of alpha interferon signaling. J Virol 77:3360–3370
Grogan CC, Moyer SA (2001) Sendai virus wild-type and mutant C proteins show a direct correlation between L polymerase binding and inhibition of viral RNA synthesis. Virology 288:96–108
Gubbay O, Curran J, Kolakofsky D (2001) Sendai virus genome synthesis and assembly are coupled: a possible mechanism to promote viral RNA polymerase processivity. J Gen Virol 82:2895–2903
Gupta KC, Patwardhan S (1988) ACG, the initiator codon for Sendai virus C protein. J Biol Chem 263:8553–8556
Hamaguchi M, Yoshida T, Nishikawa K, Naruse H, Nagai Y (1983) Transcriptive complex of Newcastle disease virus. I. Both L and P proteins are required to constitute an active complex. Virology 128:105–117
Harrison MS, Sakaguchi T, Schmitt AP (2010) Paramyxovirus assembly and budding: building particles that transmit infections. Int J Biochem Cell Biol 42:1416
Hasan MK, Kato A, Shioda T, Sakai Y, Yu D, Nagai Y (1997) Creation of an infectious recombinant Sendai virus expressing the firefly luciferase gene from the 3′ proximal first locus. J Gen Virol 78:2813–2820
Hasan MK, Kato A, Muranaka M, Yamaguchi R, Sakai Y, Hatano I, Tashiro M, Nagai Y (2000) Versatility of the accessory C proteins of Sendai virus. Contribution to virus assembly as an additional role. J Virol 74:5619–5628
Heggeness MH, Scheid A, Choppin PW (1981) The relationship of conformational changes in the Sendai virus nucleocapsid to proteolytic cleavage of the NP polypeptide. Virology 114:555–562
Heggeness MH, Smith PR, Choppin PW (1982) In vitro assembly of the nonglycosylated membrane protein (M) of Sendai virus. Proc Natl Acad Sci U S A 79:6232–6236
Hendricks DD, Ono E, Seyer JM, Gupta KC (1993) Phosphorylation of the Sendai virus C proteins. Virology 197:471–474
Hewitt JA, Nermut MV (1977) A morphological study of the M-protein of Sendai virus. J Gen Virol 34:127–136
Heylbroeck C, Balachandran S, Servant MJ, DeLuca C, Barber GN, Lin R, Hiscott J (2000) The IRF-3 transcription factor mediates Sendai virus-induced apoptosis. J Virol 74:3781–3792
Hidaka Y, Kanda T, Iwasaki K, Nomoto A, Shioda T, Shibuta H (1984) Nucleotide sequence of Sendai virus genome region covering the entire M gene and the 3′ proximal 1013 nucleotides of the F gene. Nucleic Acids Res 12:7965–7973
Holmes DE, Moyer SA (2002) The phosphoprotein (P) binding site resides in the N terminus of the L polymerase subunit of Sendai virus. J Virol 76:3078–3083
Homma M, Ouchi M (1973) Trypsin action on the growth of Sendai virus in tissue culture cells. III. Structural difference of Sendai viruses grown in eggs and tissue culture cells. J Virol 12:1457–1465
Horikami SM, Curran J, Kolakofsky D, Moyer SA (1992) Comlpexes of Sendai virus NP-P and P-L proteins are required for defective interfering particle genome replication in vitro. J Virol 66:4901–4908
Horikami SM, Hector RE, Smallwood S, Moyer SA (1997) The Sendai virus C protein binds the L polymerase protein to inhibit viral RNA synthesis. Virology 235:261–270
Hornung V, Ellegast J, Kim S, Brzózka K, Jung A, Kato H, Poeck H, Akira S, Conzelmann KK, Schlee M, Endres S, Hartmann G (2006) 5′-Triphosphate RNA is the ligand for RIG-I. Science 314:994–997
Hosaka Y (1968) Isolation and structure of the nucleocapsid of HVJ. Virology 35:445–457
Hosaka Y, Kitano H, Ikeguchi S (1966) Studies on the pleomorphism of HVJ virions. Virology 29:205–221
Houben K, Marion D, Tarbouriech N, Ruigrok RWH, Blanchard L (2007) Interaction of the C-terminal domains of Sendai virus N and P proteins: comparison of polymerase-nucleocapsid interactions within the paramyxovirus family. J Virol 81:6807–6816
Howe C, Morgan C (1969) Interactions between Sendai virus and human erythrocytes. J Virol 3:70–81
Hu C-J, Gupta KC (2000) Functional significance of alternate phosphorylation in Sendai virus P protein. Virology 268:517–532
Hu C, Kato A, Bowman MC, Kiyotani K, Yoshida T, Moyer SA, Nagai Y, Gupta KC (1999) Role of primary constitutive phosphorylation of Sendai virus P and V proteins in viral replication and pathogenesis. Virology 263:195–208
Huang C, Kiyotani K, Fujii Y, Fukuhara N, Kato A, Nagai Y, Yoshida T, Sakaguchi T (2000) Involvement of the zinc-binding capacity of Sendai virus V protein in viral pathogenesis. J Virol 74:7834–7841
Hughes S, Mellstrom K, Kosik E, Tamanoi F, Brugge J (1984) Mutation of a termination codon affects src initiation. Mol Cell Biol 4:1738–1746
Huntley CC, De BP, Banerjee AK (1997) Phosphorylation of Sendai virus phosphoprotein by cellular protein kinase C ζ. J Biol Chem 272:16578–16584
Inoue M, Tokusumi Y, Ban H, Kanaya T, Tokusumi T, Nagai Y, Iida A, Hasegawa M (2003a) Nontransmissible virus-like particle formation by F-deficient Sendai virus is temperature sensitive and reduced by mutations in M and HN proteins. J Virol 77:3238–3246
Inoue M, Tokusumi Y, Ban H, Kanaya T, Shirakura M, Tokusumi T, Hirata T, Nagai Y, Iida A, Hasegawa M (2003b) A new type of Sendai virus vector deficient in the matrix gene has lost virus particle formation and gained extensive cell-to-cell spreading. J Virol 77:6419–6429
Irie T, Shimazu Y, Yoshida T, Sakaguchi T (2007) The YLDL sequence within Sendai virus M protein is critical for budding of virus-like particles and interacts with Alix/AIP1 independently of C protein. J Virol 81:2263–2273
Irie T, Nagata N, Yoshida T, Sakaguchi T (2008a) Paramyxovirus Sendai virus C proteins are essential for maintenance of negative-sense RNA genome in virus particles. Virology 374:495–505
Irie T, Nagata N, Yoshida T, Sakaguchi T (2008b) Recruitment of Alix/AIP1 to the plasma membrane by Sendai virus C protein facilitates budding of virus-like particles. Virology 371:108–120
Irie T, Inoue M, Sakaguchi T (2010) Significance of the YLDL motif in the M protein and Alix/AIP1 for Sendai virus budding in the context of virus infection. Virology 405:334–341
Irie T, Kiyotani K, Igarashi T, Yoshida A, Sakaguchi T (2012) Inhibition of interferon regulatory factor 3 activation by paramyxovirus V protein. J Virol 86:7136–7145
Irie T, Okamoto I, Yoshida A, Nagai Y, Sakaguchi T (2014) Sendai virus C proteins regulate viral genome and antigenome synthesis to dictate the negative genome polarity. J Virol 88:690–698
Ishida N, Homma M (1978) Sendai virus. Adv Virus Res 23:349–383
Ito T, Suzuki Y, Takada A, Kawamoto A, Otsuki K, Masuda H, Yamada M, Suzuki T, Kida H, Kawaoka Y (1997) Differences in sialic acid-galactose linkages in the chicken egg amnion and allantois influence human influenza virus receptor specificity and variant selection. J Virol 71:3357–3362
Iwata S, Schmidt AC, Titani K, Suzuki M, Kido H, Gotoh B, Hamaguchi M, Nagai Y (1994) Assignment of disulfide bridges in the fusion glycoprotein of Sendai virus. J Virol 68:3200–3206
Kato A, Sakai Y, Shioda T, Kondo T, Nakanishi M, Nagai Y (1996) Initiation of Sendai virus multiplication from transfected viral cDNA or RNA with negative or positive sense. Genes Cells 1:569–579
Kato A, Kiyotani K, Sakai Y, Yoshida T, Nagai Y (1997a) The paramyxovirus, Sendai virus, V protein encodes a luxury function required for viral pathogenesis. EMBO J 16:578–587
Kato A, Kiyotani K, Sakai Y, Yoshida T, Shioda T, Nagai Y (1997b) Importance of the cysteine-rich carboxyl-terminal half of V protein for Sendai virus pathogenesis. J Virol 71:7266–7272
Kato A, Kiyotani K, Hasan MK, Shioda T, Sakai Y, Yoshida T, Nagai Y (1999) Sendai virus gene start signals are not equivalent in reinitiation capacity: moderation at the F gene. J Virol 73:9237–9246
Kato A, Ohnishi Y, Kohase M, Saito S, Tashiro M, Nagai Y (2001) Y2, the smallest of the Sendai virus C proteins, is fully capable of both counteracting the antiviral action of interferons and inhibiting viral RNA synthesis. J Virol 75:3802–3810
Kato A, Ohnishi Y, Hishiyama M, Kohase M, Saito S, Tashiro M, Nagai Y (2002) The amino-terminal half of Sendai virus C protein is not responsible for either counteracting the antiviral action of interferons or down- regulating viral RNA synthesis. J Virol 76:7114–7124
Kato A, Cortese-Grogan C, Moyer SA, Sugahara F, Sakaguchi T, Kubota T, Otsuki N, Kohase M, Tashiro M, Nagai Y (2004) Characterization of the amino acid residues of sendai virus C protein that are critically involved in its interferon antagonism and RNA synthesis down-regulation. J Virol 78:7443–7454
Kato A, Kiyotani K, Kubota T, Yoshida T, Tashiro M, Nagai Y (2007) Importance of the anti-interferon capacity of Sendai virus C protein for pathogenicity in mice. J Virol 81:3264–3271
Kido H, Yokogoshi Y, Sakai K, Tashiro M, Kishino Y, Fukutomi A, Katunuma N (1992) Isolation and characterization of a novel trypsin-like protease found in rat bronchiolar epithelial Clara cells: a possible activator of the viral fusion glycoprotein. J Biol Chem 267:13573–13579
Kido H, Okumura Y, Yamada H, Le TQ, Yano M (2007) Proteases essential for human influenza virus entry into cells and their inhibitors as potential therapeutic agents. Curr Pharm Des 13:405–414
Kimura Y, Ito Y, Shimokawa K, Nishiyama Y, Nagata I, Kitoh J (1975) Temperature-sensitive virus derived from BHK cells persistently infected with HVJ (Sendai virus). J Virol 15:55–63
Kiyotani K, Takao S, Sakaguchi T, Yoshida T (1990) Immediate protection of mice from lethal wild-type Sendai virus (HVJ) infections by a temperature-sensitive mutant, HVJpi, possessing homologous interfering capacity. Virology 177:65–74
Kiyotani K, Sakaguchi T, Kato A, Nagai Y, Yoshida T (2007) Paramyxovirus Sendai virus V protein counteracts innate virus clearance through IRF-3 activation, but not via interferon, in mice. Virology 359:82–91
Klenk HD, Garten W (1994) Host cell proteases controlling virus pathogenicity. Trends Microbiol 2:39–43
Kolakofsky D, Bruschi A (1975) Antigenomes in Sendai virions and Sendai virus-infected cells. Virology 66:185–191
Kolakofsky D, Boy de la Tour E, Bruschi A (1974) Self-annealing of Sendai virus RNA. J Virol 14:33–39
Kolakofsky D, Pelet T, Garcin D, Hausmann S, Curran J, Roux L (1998) Paramyxovirus RNA synthesis and the requirement for hexamer genome length: the rule of six revisited. J Virol 72:891–899
Kolokoltsov AA, Deniger D, Fleming EH, Roberts NJ Jr, Karpilow JM, Davey RA (2007) Small interfering RNA profiling reveals key role of clathrin-mediated endocytosis and early endosome formation for infection by respiratory syncytial virus. J Virol 81:7786–7800
Komatsu T, Takeuchi K, Yokoo J, Tanaka Y, Gotoh B (2000) Sendai virus blocks alpha interferon signaling to signal transducers and activators of transcription. J Virol 74:2477–2480
Komatsu T, Takeuchi K, Yokoo J, Gotoh B (2002) Sendai virus C protein impairs both phosphorylation and dephosphorylation processes of Stat1. FEBS Lett 511:139–144
Kondo T, Yoshida T, Miura N, Nakanishi M (1993) Temperature sensitive phenotype of a mutant Sendai virus strain is caused by its insufficient accumulation of the M protein. J Biol Chem 268:21924–21930
Koyama AH, Ogawa M, Kato A, Nagai Y, Adachi A (2001) Lack of apoptosis in Sendai virus-infected Hep-2 cells without participation of viral antiapoptosis gene. Microbes Infect 3:1115–1121
Koyama AH, Irie H, Kato A, Nagai Y, Adachi A (2003) Virus multiplicaiton and induction of apoptosis by Sendai virus: role of the C proteins. Microbes Infect 5:373–378
Kozak M (1984) Selection of initiation sites by eucaryotic ribosomes: effect of inserting AUG triplets upstream from the coding sequence for preproinsulin. Nucleic Acids Res 12:3873–3893
Kozak M (1987) Effects of intercistronic length on the efficiency of reinitiation by eucaryotic ribosomes. Mol Cell Biol 7:3438–3445
Kurotani A, Kiyotani K, Kato A, Shioda T, Sakai Y, Mizumoto K, Yoshida T, Nagai Y (1998) The Sendai virus, C proteins are categorically nonessential gene products but silencing their expression severely impairs viral replecation and pathogenesis. Genes Cells 3:111–124
Kuroya M, Ishida N, Shiratori T (1953) Newborn virus pneumonitis (type Sendai) II. Report: The isolation of a new virus possessing hemagglutinin activity. Yokohama Med Bull 4:217–233
Lamb RA, Choppin PW (1977a) The synthesis of Sendai virus polypeptides in infected cells. II. Instracellular distribution of polypeptides. Virology 81:371–381
Lamb RA, Choppin PW (1977b) The synthesis of Sendai virus polypeptides in infected cells. III. Phosphorylation of polypeptides. Virology 81:382–397
Lamb RA, Parks GD (2007) Paramyxoviridae: the viruses and their replication. In: Knipe DM, Howley PM (eds) Fields virology, vol 1, 5th edn. Lippincott, Williams & Wilkins, Philadelphia, pp 1449–1496
Lamb RA, Mahy BW, Choppin PW (1976) The synthesis of Sendai virus polypeptides in infected cells. Virology 69:116–131
Latorre P, Kolakofsky D, Curran J (1998) Sendai virus Y proteins are initiated by a ribosomal shunt. Mol Cell Biol 18:5021–5031
Leyrer S, Neubert WJ, Sedlmeier R (1998) Rapid and efficient recovery of Sendai virus from cDNA: factors influencing recombinant virus rescue. J Virol Methods 75:47–58
Li HO, Zhu Y-F, Asakawa M, Kuma H, Hirata T, Ueda Y, Lee Y-S, Fukumura M, Iida A, Kato T, Nagai Y, Hasegawa M (2000) A cytoplasmic RNA vector derived from non-transmissible Sendai virus with efficient gene transfer and expression. J Virol 74:6564–6569
Li M, Schmitt PT, Li Z, McCrory TS, He B, Schmitt AP (2009) Mumps virus matrix, fusion, and nucleocapsid proteins cooperate for efficient production of virus-like particles. J Virol 83:7261–7272
Liu C-C, Simonsen CC, Levinson AD (1984) Initiation of translation at internal AUG codons in mammalian cells. Nature (Lond) 309:82–85
Loney C, Mottet-Osman G, Roux L, Bhella D (2009) Paramyxovirus ultrastructure and genome packaging: cryo-electron tomography of Sendai virus. J Virol 83:8191–8197. doi:10.1128/JVI.00693-09
Luque LE, Russell CJ (2007) Spring-loaded heptad repeat residues regulate the expression and activation of paramyxovirus fusion protein. J Virol 81:3130–3141
Luque LE, Bridges OA, Mason JN, Boyd KL, Portner A, Russell CJ (2010) Residues in the heptad repeat a region of the fusion protein modulate the virulence of Sendai virus in mice. J Virol 84:810–821. doi:10.1128/JVI.01990-09
Lyles DS, Rupprecht CE (2007) Rhabdoviridae. In: Knipe DM, Howley PM (eds) Fields virology, vol 1, 5th edn. Lippincott, Williams & Wilkins, Philadelphia, pp 1363–1408
Markwell MA, Fox CF (1980) Protein–protein interactions within paramyxoviruses identified by native disulfide bonding or reversible chemical cross-linking. J Virol 33:152–166
Markwell MAK, Paulson JC (1980) Sendai virus utilizes specific sialyloligosaccharides as host cell receptor determinants. Proc Natl Acad Sci USA 77:5693–5697
Markwell MA, Portner A, Schwartz AL (1985) An alternative route of infection for viruses: entry by means of the asialoglycoprotein receptor of a Sendai virus mutant lacking its attachment protein. Proc Natl Acad Sci USA 82:978–982
Marq J-B, Brini A, Kolakofsky D, Garcin D (2007) Targeting of the Sendai virus C protein to the plasma membrane via a peptide-only membrane anchor. J Virol 81:3187–3197
Matsuoka Y, Curran J, Pelet T, Kolakofsky D, Ray R, Compans RW (1991) The P gene of human parainfluenza virus type 1 encodes P and C proteins but not a cysteine-rich V protein. J Virol 65:3406–3410
Miyauchi K, Kim Y, Latinovic O, Morozov V, Melikyan GB (2009) HIV enters cells via endocytosis and dynamin-dependent fusion with endosomes. Cell 137:433–444
Morgan C, Howe C (1968) Structure and development of viruses as observed in the electron microscope. IX. Entry of parainfluenza I (Sendai) virus. J Virol 2:1122–1132
Mottet G, Roux L (1989) Budding efficiency of Sendai virus nucleocapsids: influence of size and ends of the RNA. Virus Res 14:175–187
Mottet-Osman G, Iseni F, Pelet T, Wiznerowics M, Garcin D, Roux L (2007) Suppression of the Sendai virus M protein through a novel short interfering RNA approach inhibits viral particle production but does not affect viral RNA analysis. J Virol 81:2861–2868
Moyer SA, Baker SC, Lessard JL (1986) Tublin: a factor necessary for the synthesis of both Sendai virus and vesicular stomatitis virus RNAs. Proc Natl Acad Sci USA 83:5405–5409
Murphy AM, Grdzelishvili VZ (2009) Identification of Sendai virus L protein amino acid residues affecting viral mRNA cap methylation. J Virol 83:1669–1681. doi:10.1128/JVI.01438-08
Myers TM, Moyer SA (1997) An amino-terminal domain of the Sendai virus nucleocapsid protein is required for template function. J Virol 71:918–924
Nagai Y (1993) Protease-dependent virus tropism and pathogenicity. Trends Microbiol 1:81–87
Nagai Y (1995) Virus activation by host proteinases. A pivotal role in the spread of infection, tissue tropism and pathogenicity. Microbiol Immunol 39:1–9
Nagai Y (1999) Paramyxovirus replication and pathogenesis. Reverse genetics transforms understanding. Rev Med Virol 9:83–99
Nagai Y, Kato A (1999) Paramyxovirus reverse genetics is coming of age. Microbiol Immunol 43:613–624
Nagai Y, Kato A (2004) Accessory genes of the Paramyxoviridae, a large family of nonsegmented negative-strand and RNA viruses, as a focus of active investigation by reverse genetics. Curr Top Microbiol Immunol 283:197–248
Nagai Y, Yoshida T (1984) Viral pathogenesis: mechanism of acute and persistent infections with paramyxoviruses. Nagoya J Med Sci 46:1–17
Nagai Y, Ogura H, Klenk H-D (1976a) Studies on the assembly of the envelope of Newcastle disease virus. Virology 69:523–538
Nagai Y, Klenk H-D, Rott R (1976b) Proteolytic cleavage of the viral glycoproteins and its significance for the virulence of Newcastle disease virus. Virology 72:494–508
Nagai Y, Hamaguchi M, Toyoda T, Yoshida T (1983a) The uncoating of paramyxoviruses may not require a low pH mediated step. Virology 130:263–268
Nagai Y, Yoshida T, Hamaguchi M, Nagura H, Hasegawa H, Yoshimura S, Watanabe K (1983b) Subcellular location of the major protein antigens of paramyxoviruses revealed by immunoperoxidase cytochemistry. Microbiol Immunol 27:531–545
Nagai Y, Inoue M, Iida A, Zhu Y-F, Hasegawa M, Kato A, Matano T (2007) Sendai virus engineering: from reverse genetics to vector development. In: Hefferon KL (ed) Virus expression vectors. Transworld Research Network, Kerala, pp 123–146
Nagai Y, Takakura A, Irie T, Yonemitsu Y, Gotoh B (2011) Sendai virus evolution from mouse pathogen to a state-of-the-art tool in virus research and biotechnology. In: Samal SK (ed) The biology of paramyxoviruses. Caister Academic, Norfolk
Nagata I, Kimura Y, Ito Y, Tanaka T (1972) Temperature-sensitive phenomenon of viral maturation observed in BHK cells persistently infected with HVJ. Virology 49:453–461
Nishimura K, Segawa H, Goto T, Morishita M, Masago A, Takahashi H, Ohmiya Y, Sakaguchi T, Asada M, Imamura T, Shimotono K, Takayama K, Yoshida T, Nakanishi M (2007) Persistent and stable gene expression by a cytoplasmic RNA replicon based on a noncytopathic variant Sendai virus. J Biol Chem 282:27383–27391
Nishio M, Nagata A, Tsurudome M, Ito M, Kawano M, Komada H, Ito Y (2004) Recombinant Sendai viruses with L1618V mutation in their L polymerase protein establish persistent infection, but not temperature sensitivity. Virology 329:289–301
Ogasawara T, Gotoh B, Suzuki H, Asaka J, Shimokata K, Rott R, Nagai Y (1992) Expression of factor X and its significance for the determination of paramyxovirus tropism in the chick embryo. EMBO J 11:467–472
Ogino T, Kobayashi M, Iwama M, Mizumoto K (2005) Sendai virus RNA-dependent RNA polymerase L protein catalyzes cap methylation of virus-specific mRNA. J Biol Chem 280:4429–4435
Ohnishi Y, Shioda T, Nakayama K, Iwata S, Gotoh B, Hamaguchi M, Nagai Y (1995) A furin-defective cell line is able to process correctly the gp160 of human immunodeficiency virus type 1. J Virol 68:4075–4079
Palese P, Zheng H, Engelhardt OG, Pleschka S, GarcÃa-Sastre A (1996) Negative-strand RNA viruses: genetic engineering and applications. Proc Natl Acad Sci USA 93:11354–11358
Pennington TH, Pringle CR (1978) Negative strand viruses in enucleate cells. In: Mahy BWJ, Barry RD (eds) Negative strand viruses and the host cell. Academic, New York
Peters K, Chattopadhyay S, Sen GC (2008) IRF-3 activation by Sendai virus infection is required for cellular apoptosis and avoidance of persistence. J Virol 82:3500–3508
Poch O, Blumberg BM, Bougueleret L, Tordo N (1990) Sequence comparison of five polymerases (L proteins) of unsegmented negative-strand RNA viruses: theoretical assignment of functional domains. J Gen Virol 71:1153–1162
Portner A, Murti KG (1986) Localization of P, NP, and M proteins on Sendai virus nucleocapsid using immunogold labeling. Virology 150:469–478
Portner A, Gupta KC, Seyer JM, Beachey EH, Kingsbury DW (1986) Localization and characterization of Sendai virus nonstructural C and C’ proteins by antibodies against synthetic peptides. Virus Res 6:109–121
Portner A, Murti KG, Morgan EM, Kingsbury DW (1988) Antibodies against Sendai virus L protein: distribution of the protein in nucleocapsids revealed by immunoelectron microscopy. Virology 163:236–239
Qanungo KR, Shaji D, Mathur M, Banerjee AK (2004) Two RNA polymerase complexes from vesicular stomatitis virus-infected cells that carry out transcription and replication of genome RNA. Proc Natl Acad Sci USA 101:5952
Radoshitzky SR, Dong L, Chi X, Clester JC, Retterer C, Spurgers K, Kuhn JH, Sandwick S, Ruthel G, Kota K, Bolts D, Warren T, Kranzusch PJ, Whelan SPJ, Bavari S (2010) Infectious Lassa virus, but not filoviruses, is restricted by BST-2/tetherin. J Virol 84:10569–10580. doi:10.1128/JVI.00103-10
Randall RE, Goodbourn S (2008) Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures. J Gen Virol 89:1–47
Randall RE, Russell WC (1991) Paramyxovirus persistence: consequences for host and virus. In: Kingsbury DW (ed) The paramyxoviruses. Plenum, New York, pp 299–321
Re GG (1991) Deletion mutants of paramyxoviruses. In: Kingsbury DW (ed) The paramyxoviruses. Plenum, New York, pp 275–298
Re GG, Kingsbury DW (1986) Nucleotide sequences that affect replicative and transcriptional efficiencies of Sendai virus deletion mutants. J Virol 58:578–582
Rima BK, Martin SJ (1976) Persistent infection of tissue culture cells by RNA viruses. Med Microbiol Immunol 162:89–118
Roux L, Holland JJ (1979) Role of defective interfering particles of Sendai virus in persistent infections. Virology 93:91–103
Roux L, Holland JJ (1980) Viral genome synthesis in BHK-21 cells persistently infected with Sendai virus. Virology 100:53–64
Ryan KW, Morgan EM, Portner A (1991) Two noncontiguous regions of Sendai virus P protein combine to form a single nucleocapsid binding domain. Virology 180:126–134
Sakaguchi T, Toyoda T, Gotoh B, Inocencio NM, Kuma K, Miyata T, Nagai Y (1989) Newcastle disease virus evolution. I. Multiple lineages defined by sequence variability of the hemagglutinin-neuraminidase gene. Virology 169:260–272
Sakaguchi T, Kiyotani K, Kato A, Asakawa M, Fujii Y, Nagai Y, Yoshida T (1997) Phosphorylation of the Sendai virus M protein is not essential for virus replication either in vitro or in vivo. Virology 235:360–366
Sakaguchi T, Uchiyama T, Huang C, Fukuhara N, Kiyotani K, Nagai Y, Yoshida T (2002) Alteration of Sendai virus morphogenesis and nucleocapsid incorporation due to mutation of cycteine residues of the matrix protein. J Virol 76:1682–1690
Sakaguchi T, Kato A, Sugahara F, Shimazu Y, Inoue M, Kiyotani K, Nagai Y, Yoshida T (2005) AIP1/Alix is a binding partner of Sendai virus C protein and facilitates virus budding. J Virol 79:8933–8941
Sakaguchi T, Kato A, Kiyotani K, Yoshida T, Nagai Y (2008) Studies on the paramyxovirus accessory genes by reverse genetics in the Sendai virus–mouse system. Proc Jpn Acad Ser B Phys Biol Sci 84:439–451
Sanderson CM, Avalos R, Kundu A, Nayak DP (1995) Interaction of Sendai virus F, HN, and M proteins with host cytoskeletal and lipid components in Sendai virus-infected BHK cells. Virology 209:701–707
Scheid A, Choppin PW (1974) Identification of biological activities of paramyxovirus glycoproteins. Activation of cell fusion, hemolysis, and infectivity of proteolytic cleavage of an inactive precursor protein of Sendai virus. Virology 57:475–490
Schmitt AP, Leser GP, Morita E, Sundquist WI, Lamb RA (2005) Evidence for a new viral late domain core sequence, FPIV, necessary for budding of a paramyxovirus. J Virol 79:2988–2997
Schnell MJ, Mebatsion T, Conzelmann K-K (1994) Infectious rabies virus from cloned cDNA. EMBO J 13:4195–4203
Segawa H, Yamashita T, Kawakita M, Taira H (2000) Functional analysis of the individual oligosaccharide chains of Sendai virus fusion protein. J Biochem 128:65–72
Segawa H, Inakawa A, Yamashita T, Taira H (2003) Functional analysis of individual oligosaccharide chains of Sendai virus hemagglutinin-neuraminidase protein. Biosci Biotechnol Biochem 67:592–598
Shimazu Y, Takao SI, Irie T, Kiyotani K, Yoshida T, Sakaguchi T (2008) Contribution of the leader sequence to homologous viral interference among Sendai virus strains. Virology 372:64–71
Shimizu K, Ishida N (1975) The smallest protein of Sendai virus: its candidate function of binding nucleocapsid to envelope. Virology 67:427–437
Shimizu YK, Shimizu K, Ishida N, Homma M (1976) On the study of Sendai virus hemolysis. II. Morphological study of envelope fusion and hemolysis. Virology 71:48–60
Shioda T, Hidaka Y, Kanda T, Shibuta H, Nomoto A, Iwasaki K (1983) Sequence of 3,687 nt from the 3′ end of Sendai virus genome RNA and the predicted amino acid sequences of viral NP, P and C proteins. Nucleic Acids Res 11:7317–7330
Shioda T, Iwasaki K, Shibuta H (1986) Determination of the complete nucleotide sequence of the Sendai virus genome RNA and the predicted amino acid sequence of the F, HN, and L proteins. Nucleic Acids Res 14:1545–1563
Shirogane Y, Takeda T, Iwasaki M, Ishiguro N, Takeuchi H, Nakatsu Y, Tahara M, Kikuta H, Yanagi Y (2008) Efficient multiplication of human metapneumovirus in Vero cells expressing the transmembrane serine protease TMPRSS2. J Virol 82:8942–8946
Smallwood S, Ryan KW, Moyer SA (1994) Deletion analysis defines a carboxyl-proximal region of Sendai virus P protein that binds to the polymerase L protein. Virology 202:154–163
Smallwood S, Hövel T, Neubert WJ, Moyer SA (2002a) Different substitutions at conserved amino acids in domains II and III in the Sendai L RNA polymerase protein inactivate viral RNA synthesis. Virology 304:135–145
Smallwood S, Çevik B, Moyer SA (2002b) Intragenic complementation and oligomerization of the L subunit of the Sendai virus RNA polymerase. Virology 304:235–245
Sriwilaijaroen N, Kondo S, Yagi H, Wilairat P, Hiramatsu H, Ito M, Ito Y, Kato K, Suzuki Y (2009) Analysis of N-glycans in embryonated chicken egg choriollantoic and amniotic cells responsible for binding and adaptation of human and avian influenza viruses. Glycoconj J 26:433–443
Sugahara F, Uchiyama T, Watanabe H, Shimazu Y, Kuwayama M, Fujii Y, Kiyotani K, Adachi A, Kohno N, Yoshida T, Sakaguchi T (2004) Paramyxovirus Sendai virus-like particle formation by expression of multiple viral proteins and acceleration of its release by C protein. Virology 325:1–10
Suzuki Y, Suzuki T, Matsumoto M (1983) Isolation and characterization of receptor sialoglycoprotein for hemagglutinating virus of Japan (Sendai virus) from bovine erythrocyte membrane. J Biochem (Tokyo) 93:1621–1633
Suzuki Y, Suzuki T, Matsunaga M, Matsumoto M (1985) Gangliosides as paramyxovirus receptor. Structural requirement of sialo-oligosaccharides in receptors for hemagglutinating virus of Japan (Sendai virus) and Newcastle disease virus. J Biochem (Tokyo) 97:1189–1199
Suzuki H, Harada A, Hayashi Y, Wada K, Asaka J, Gotoh B, Ogasaweara T, Nagai Y (1991) Primary structure of the virus activating protease from chick embryo; its identity with the blood clotting factor Xa. FEBS Lett 283:281–285
Takimoto T, Bousse T, Coronel EC, Scroggs RA, Portner A (1998) Cytoplasmic domain of Sendai virus HN protein contains a specific sequence required for its incorporation into virions. J Virol 72:9747–9754
Tamura T, Yamashita T, Segawa H, Taira H (2002) N-linked oligosaccharide chains of Sendai virus fusion protein determine the interaction with endoplasmic reticulum molecular chaperones. FEBS Lett 513:153–158
Tapparel C, Hausmann S, Pelet T, Curran J, Kolakofsky D, Roux L (1997) Inhibition of Sendai virus genome replication due to promoter-increased selectivity: a possible role for the accessory C proteins. J Virol 71:9588–9599
Tapparel C, Maurice D, Roux L (1998) The activity of Sendai virus genomic and antigenomic promoters requires a second element past the leader template regions: a motif, (GNNNNN)3, is essential for replication. J Virol 72:3117–3128
Tarbouriech N, Curran J, Ebel C, Ruigrok RWH, Burmeister WP (2000a) On the domain structure and the polymerization state of the Sendai virus P protein. Virology 266:99–109
Tarbouriech N, Curran J, Ruigrok RWH, Burmeister WP (2000b) Tetrameric coiled coil domain of Sendai virus phosphoprotein. Nat Struct Biol 7:777–781
Tashiro M, Yokogoshi Y, Tobita K, Seto JT, Rott R, Kido H (1992) Tryptase Clara, an activating protease for Sendai virus in rat lungs, is involved in pneumopathogenicity. J Virol 66:7211–7216
Toyoda T, Sakaguchi T, Imai K, Inocencio NM, Gotoh B, Hamaguchi M, Nagai Y (1987) Structural comparison of the cleavage-activation site of the fusion glycoprotein between virulent and avirulent strains of Newcastle disease virus. Virology 158:242–247
Toyoda T, Sakaguchi T, Hirota H, Gotoh B, Kuma K, Miyata T, Nagai Y (1989) Newcastle disease virus evolution. II. Lack of gene recombination in generating virulent and avirulent strains. Virology 169:273–282
Tozawa H, Watanabe M, Ishida N (1973) Structural components of Sendai virus. Serological and physicochemical characterization of hemagglutinin subunit associated with neuraminidase activity. Virology 55:242–253
Vidal S, Curran J, Kolakofsky D (1990a) Editing of the Sendai virus P/C mRNA by G insertion occurs during mRNA synthesis via a virus-encoded activity. J Virol 64:239–246
Vidal S, Curran J, Kolakofsky D (1990b) A stuttering model for paramyxovirus P mRNA editing. EMBO J 9:2017–2022
Watanabe R, Leser GP, Lamb RA (2011) Influenza virus is not restricted by tetherin whereas influenza VLP production is restricted by teterin. Virology 417:50–56
Whelan SP, Wertz GW (2002) Transcription and replication initiate at separate sites on the vesicular stomatitis virus genome. Proc Natl Acad Sci USA 99:9178–9183
Whelan SPJ, Barr JN, Wertz GW (2004) Transcription and replication of nonsegmented negative-strand RNA viruses. Curr Top Microbiol Immunol 283:61–119
Wiegand MA, Bossow S, Schlecht S, Neubert WJ (2007) De novo synthesis of N and P proteins as a key step in Sendai gene expression. J Virol 81:13835–13844. doi:10.1128/JVI.00914-07
Yamada H, Hayata S, Omata-Yamada T, Taira H, Mizumoto K, Iwasaki K (1990) Association of the Sendai virus C protein with nucleocapsids. Arch Virol 113:245–253
Yoshida T, Nagai Y, Yoshii S, Maeno K, Matsumoto T, Hoshino M (1976) Membrane (M) protein of HVJ (Sendai virus): its role in virus assembly. Virology 71:143–161
Yoshida T, Nagai Y, Maeno K, Iinuma M, Hamaguchi M, Matsumoto T (1979) Studies on the role of M protein in virus assembly using a TS mutant of HVJ (Sendai virus). Virology 92:139–154
Yoshida T, Hamaguchi M, Naruse H, Nagai Y (1982) Persistent infection by a temperature-sensitive mutant isolated from a Sendai virus (HVJ) carrier culture: its initiation and maintenance without aid of defective interfering particles. Virology 120:329–339
Yoshima H, Nakanishi M, Okada Y, Kobata A (1981) Carbohydrate structures of HVJ (Sendai virus) glycoproteins. J Biol Chem 256:5355–5361
Young DF, Didcock L, Goodbourn S, Randall RE (2000) Paramyxoviridae use distinct virus-specific mechanisms to circumvent the interferon response. Virology 269:383–390
Youngner JS, Preble OT (1980) Viral persistence: evolution of viral populations. In: Frankel-Conrat H, Wagner RR (eds) Comprehensive virology, vol 16. Plenum, New York/London, pp 73–135
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Japan
About this chapter
Cite this chapter
Nagai, Y., Kato, A. (2013). Sendai Virus Biology and Engineering Leading up to the Development of a Novel Class of Expression Vector. In: Nagai, Y. (eds) Sendai Virus Vector. Springer, Tokyo. https://doi.org/10.1007/978-4-431-54556-9_2
Download citation
DOI: https://doi.org/10.1007/978-4-431-54556-9_2
Published:
Publisher Name: Springer, Tokyo
Print ISBN: 978-4-431-54555-2
Online ISBN: 978-4-431-54556-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)